FDA ready to crack down as Novartis reveals manipulated Zolgensma data

6th August 2019 Uncategorised 0

The FDA is weighing penalties for Novartis over revelations that its application for gene therapy Zolgensma contained manipulated data.

More: FDA ready to crack down as Novartis reveals manipulated Zolgensma data
Source: fierce